The cellular stores of iron in granulocytes and platelets isolated from 29 patients with ankylosing spondylitis were measured by the nuclear microprobe technique. The mean iron content in polymorphonuclear cells (PMNs) was 32 (SD 3) ,ug/g dry weight and in platelets 11 (2) (3) (4) (5) (6) [ig/g dry weight. Corresponding values for age and sex matched healthy controls were 5 2 (1-9) and 4-6 (0-8) [tg/g (p<0-001). Significant correlations were found in the patient group between (PMN) iron and the circulating levels of transferrin, total iron, and lactoferrin (p<005). PMN iron was not related to serum ferritin. Platelet iron correlated with transferrin (p<0-01) but not with the other iron binding proteins. Significant relationships were also found between the PMN iron stores and the inflammatory activity defined by erythrocyte sedimentation rate (ESR) and the immunoglobulins A and G. These data further illustrate the altered iron kinetics in chronic inflammatory disease and record the fact that the redistribution of iron associated with the inflammatory process also includes granulocytes and platelets.
The anaemia and hypoferraemia of inflammatory disease have been widely discussed. Both beneficial and noxious effects in the inflammatory processes have been attributed to iron. Studies of iron kinetics in inflammatory disease have shown abnormal accumulation of iron in RE 
Results
The iron stores in granulocytes and platelets isolated from patients with ankylosing spondylitis and healthy controls are presented in Fig. 1 The inflammatory activity of the patients was defined by ESR, and serum levels of haptoglobin, IgG, and IgA. PMN iron was significantly correlated with the immunoglobulin levels and tended to correlate with the inflammatory activity defined by ESR and haptoglobin (Fig. 2) . Platelet iron did not correlate with these variables reflecting disease activity (data not shown). Weak but significant relationships (p<0-05) were observed between PMN iron stores and plasma lactoferrin, transferrin, and total serum iron but not with serum ferritin (Fig. 3) . Platelet iron correlated with transferrin Previous studies of the altered iron kinetics in inflammatory disease have suggested different mechanisms behind this phenomenon. Interleukin-1 which induces fever, leucocytosis, and an alteration in acute phase protein synthesis also induces hypoferraemia.15 This can be due to an increased iron uptake in certain cells and to a shift to a slower recirculating pathway within the cells. 18 Similar inflammatory mechanisms may also underlie the accumulation of iron in granulocytes and platelets since a relation was found between the cellular iron stores and the laboratory signs of inflammatory activity defined by ESR and serum immunoglobulins A and G. An altered iron uptake via the intestine could also influence the iron kinetics.16 17 In an attempt to elucidate further the altered iron kinetics and to discover from where the accumulated iron is derived the iron binding proteins in serum were measured. Serum ferritin is considered to reflect the total iron stores and this is true for the anaemia of iron deficiency. An increase of serum ferritin, however, may also be part of an acute phase reaction and therefore ferritin poorly reflects the total iron stores in chronic inflammation. 18 Thus it is not surprising that we cannot find any correlation between serum ferritin and the cellular iron stores. The difficulty involved in clarifying the altered iron distribution was also illustrated by the negative correlation between serum transferrin and cellular iron stores. This might merely reflect the fact that transferrin acts as a negative acute phase reactant and does not at this point provide any simple solution. A role for lactoferrin in the altered iron metabolism has also been suggested. 19 Lactoferrin is secreted from PMNs and appears in plasma in higher concentrations during inflammation. Lactoferrin can remove iron from its normal carrier protein transferrin and this iron-lactoferrin complex is then, by means of specific receptors, taken up by RE cells. 21 Thus a cellular accumulation of iron can be achieved. Our observation that patients with ankylosing spondylitis have significantly higher plasma levels of lactoferrin than controls and that the lactoferrin values correlate with the acute phase reaction suggests an activated granulocyte mass in the disease. The observation that circulating lactoferrin correlates with the iron stores in granulocytes may suggest that mechanisms similar to those described in macrophages for the uptake of lactoferrin-iron complexes are also relevant for granulocytes. Iron binding proteins in PMNs other than lactoferrin and ferritin have been suggested but not identified.22 Granular proteins in platelets are also likely to take part in the iron storage and transport of iron.
The biological significance of the changes in iron distribution in inflammatory states could be manifold. A high cellular iron content is beneficial to the organism in certain situations and hazardous in others. Iron enhances the free radical production necessary to defeat invading bacteria, but excess of free iron promotes bacterial growth and must be prevented.23 Intracellular iron, which is not properly bound within ferritin, can in the rheumatic joint induce synthesis and release of collagenase and prostaglandins or promote the formation of toxic free radicals. 24 Patients with 24-thalassaemia, heavily iron overloaded from repeated transfusions, have neutrophils that show enhanced oxidative metabolism and increased superoxide production.25 Further evidence for the noxious effects of iron in rheumatic disease is given in the study by Blake and coworkers where intravenous iron dextran treatment is shown to promote synovitis concomitant with increased lipid peroxidation.26 Thus an initially appropriate inflammatory reaction can in the presence of excess iron be turned into a harmful and self perpetuating process. This study has shown that yet two other cell types, the PMNs and the platelets, have altered iron stores in inflammatory disease. This supports previous ideas of a crucial role for iron in these states. In order to elucidate the cellular structures that govern the storage and release of iron in inflammation further studies of subcellular organelles are needed. 
